Nutriflex Lipid Plus Novo

Valine, the active ingredient in Nutriflex Lipid Plus Novo, is a mixture of essential and non‑essential amino acids presented as a nutritional supplement for intravenous use. It supports metabolic needs in patients requiring parenteral nutrition, particularly those who are unable to meet protein requirements orally.

GNH USA supplies Nutriflex Lipid Plus Novo as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and clinics worldwide.

Nutriflex Lipid Plus Novo provides amino acids for patients with increased metabolic demand or limited oral intake. It is used in the following clinical situations: - Post‑operative recovery: Helps maintain nitrogen balance and supports tissue repair. - Severe trauma or burns: Supplies essential amino acids needed for wound healing and catabolism control. - Critical illness requiring parenteral nutrition: Provides a balanced amino acid profile to meet protein requirements when enteral feeding is not feasible.

Amino acid mixtures are generally well tolerated, but adverse reactions can occur.

Common Side Effects: - Mild nausea or gastrointestinal discomfort. - Transient elevation of liver enzymes. - Local irritation at the infusion site. - Mild electrolyte disturbances (e.g., potassium shifts). - Headache or dizziness.

Serious or Rare Side Effects: - Anaphylactic or severe hypersensitivity reaction. - Metabolic acidosis from excess amino acid load. - Hyperammonemia in patients with hepatic impairment. - Severe electrolyte imbalance requiring medical intervention.

When using Nutriflex Lipid Plus Novo, consider the following precautions: - Assess renal and hepatic function: Adjust amino acid provision in patients with organ impairment. - Monitor plasma electrolytes and acid‑base status regularly during therapy. - Evaluate nitrogen balance: Avoid over‑supplementation in patients with adequate oral intake. - Use aseptic technique: Prevent contamination of the infusion solution. - Store at ambient temperature: Keep below 25°C, protect from moisture and direct sunlight.

Amino acid solutions may interact with certain medications and clinical conditions.

Major Interactions (Avoid): - Concurrent high‑dose parenteral lipid emulsions: Risk of excessive caloric load. - Certain anticonvulsants (e.g., valproate): May increase ammonia production.

Moderate Interactions (Monitor Closely): - Loop diuretics: Can exacerbate electrolyte shifts. - Insulin therapy: May alter glucose utilization when amino acids are infused. - Renal replacement therapies: May remove amino acids from circulation, affecting dosing.